ONE-WAYDated event · through FY2026
Joint Development and Sales-Rights Licensing Partnership with MICIN for an IBS Treatment App
A project involving the joint development with MICIN of MCN-009, an app for treating irritable bowel syndrome (IBS), and the licensing of sales rights. Following execution of the agreement, the project has progressed to the stage of conducting a confirmatory clinical trial.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.
PeriodFY2026-H1 →Last written FY2026
Directionhelps1 helps · 0 hurts · 0 flat